Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 10Recruiting 4Terminated 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 7Sarcoma 4Dermatologic 4

Conditions

Sarcoma 3Leiomyosarcoma 2Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Hyperthermia 1

Interventions

Doxorubicin 25Cyclophosphamide 24pembrolizumab 20Specimen Handling 19Temozolomide 16Magnetic Resonance Spectroscopy 15Surgical Procedures, Operative 14Radiotherapy 13Blood Specimen Collection 13Biopsy 13atezolizumab 12Gemcitabine 12fludarabine 11Vincristine 11Ifosfamide 11X-Rays 8Trabectedin 8Nivolumab 8Irinotecan 8Imatinib Mesylate 8Drug Therapy 8cabozantinib 7Surveys and Questionnaires 7Radiation 7liposomal doxorubicin 5abemaciclib 5Sunitinib 5Standard of Care 5Radiation Dose Hypofractionation 5Dactinomycin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Dacarbazine × Sarcoma × Clear all
NCT03016819 2026-02-25

APROMISS

Advenchen Laboratories, LLC

Phase 3 Recruiting
325 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting
24 enrolled
Sarcoma

Hyperthermia, Sarcoma

NCT03805022 2025-10-02

CIRSARC

Institut Bergonié

Phase 3 Recruiting
351 enrolled
Sarcoma

Sarcoma

NCT04535271 2025-02-24

TAGGED

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
80 enrolled
Sarcoma

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡